Skip to main content

Table 1 Analysis of number of patients stratifying by exacerbations

From: Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials

Exacerbations a

No. of studies

Events/Total

Effect size

Heterogeneity

Macrolide

Control

OR(95%CI)

P value

I 2 (%)

P

0

8

135/277

80/267

2.81(1.85-4.26)

<0.01 *

0

0.43

1

5

37/171

31/164

1.18(0.70-2.01)

0.53

17

0.31

2

3

24/147

27/142

0.83(0.46-1.52)

0.55

34

0.22

At least 3

3

34/147

60/142

0.38(0.22-0.65)

0.0004 *

0

0.45

  1. aNumber of exacerbations per patient; bThe subgroups of at least 1 exacerbations contributed to the overall estimate;* It was suggestive of statistical significance.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us